These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 22648722)

  • 1. Supplementation with B vitamins or n-3 fatty acids and depressive symptoms in cardiovascular disease survivors: ancillary findings from the SUpplementation with FOLate, vitamins B-6 and B-12 and/or OMega-3 fatty acids (SU.FOL.OM3) randomized trial.
    Andreeva VA; Galan P; Torrès M; Julia C; Hercberg S; Kesse-Guyot E
    Am J Clin Nutr; 2012 Jul; 96(1):208-14. PubMed ID: 22648722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. B vitamin and/or ω-3 fatty acid supplementation and cancer: ancillary findings from the supplementation with folate, vitamins B6 and B12, and/or omega-3 fatty acids (SU.FOL.OM3) randomized trial.
    Andreeva VA; Touvier M; Kesse-Guyot E; Julia C; Galan P; Hercberg S
    Arch Intern Med; 2012 Apr; 172(7):540-7. PubMed ID: 22331983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. B vitamin and/or n-3 fatty acid supplementation and health-related quality of life: ancillary findings from the SU.FOL.OM3 randomized trial.
    Andreeva VA; Latarche C; Hercberg S; Briançon S; Galan P; Kesse-Guyot E
    PLoS One; 2014; 9(1):e84844. PubMed ID: 24465438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive function after supplementation with B vitamins and long-chain omega-3 fatty acids: ancillary findings from the SU.FOL.OM3 randomized trial.
    Andreeva VA; Kesse-Guyot E; Barberger-Gateau P; Fezeu L; Hercberg S; Galan P
    Am J Clin Nutr; 2011 Jul; 94(1):278-86. PubMed ID: 21593490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of B-vitamins and n-3 PUFA supplementation for 5 years on blood pressure in patients with CVD.
    Szabo de Edelenyi F; Vergnaud AC; Ahluwalia N; Julia C; Hercberg S; Blacher J; Galan P
    Br J Nutr; 2012 Mar; 107(6):921-7. PubMed ID: 21801476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular effects of B-vitamins and/or N-3 fatty acids: the SU.FOL.OM3 trial.
    Blacher J; Czernichow S; Paillard F; Ducimetiere P; Hercberg S; Galan P;
    Int J Cardiol; 2013 Jul; 167(2):508-13. PubMed ID: 22365647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Background and rationale of the SU.FOL.OM3 study: double-blind randomized placebo-controlled secondary prevention trial to test the impact of supplementation with folate, vitamin B6 and B12 and/or omega-3 fatty acids on the prevention of recurrent ischemic events in subjects with atherosclerosis in the coronary or cerebral arteries.
    Galan P; de Bree A; Mennen L; Potier de Courcy G; Preziozi P; Bertrais S; Castetbon K; Hercberg S
    J Nutr Health Aging; 2003; 7(6):428-35. PubMed ID: 14625623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Long-term Supplementation With Marine Omega-3 Fatty Acids vs Placebo on Risk of Depression or Clinically Relevant Depressive Symptoms and on Change in Mood Scores: A Randomized Clinical Trial.
    Okereke OI; Vyas CM; Mischoulon D; Chang G; Cook NR; Weinberg A; Bubes V; Copeland T; Friedenberg G; Lee IM; Buring JE; Reynolds CF; Manson JE
    JAMA; 2021 Dec; 326(23):2385-2394. PubMed ID: 34932079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Omega-3 Fatty Acids on Depressive Symptoms in HIV-Positive Individuals: A Randomized, Placebo-Controlled Clinical Trial.
    Ravi S; Khalili H; Abbasian L; Arbabi M; Ghaeli P
    Ann Pharmacother; 2016 Oct; 50(10):797-807. PubMed ID: 27323793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The SU.FOL.OM3 Study: a secondary prevention trial testing the impact of supplementation with folate and B-vitamins and/or Omega-3 PUFA on fatal and non fatal cardiovascular events, design, methods and participants characteristics.
    Galan P; Briancon S; Blacher J; Czernichow S; Hercberg S
    Trials; 2008 Jun; 9():35. PubMed ID: 18544171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of n-3 fatty acids on depressive symptoms and dispositional optimism after myocardial infarction.
    Giltay EJ; Geleijnse JM; Kromhout D
    Am J Clin Nutr; 2011 Dec; 94(6):1442-50. PubMed ID: 22030221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of B vitamins and omega 3 fatty acids on cardiovascular diseases: a randomised placebo controlled trial.
    Galan P; Kesse-Guyot E; Czernichow S; Briancon S; Blacher J; Hercberg S;
    BMJ; 2010 Nov; 341():c6273. PubMed ID: 21115589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of Marine ω-3 Fatty Acid Supplementation vs Placebo in Reducing Incidence of Dry Eye Disease in Healthy US Adults: A Randomized Clinical Trial.
    Christen WG; Cook NR; Manson JE; Buring JE; Lee IM; Bubes V; Friedenberg G; Dushkes R; Smith D; Schaumberg DA;
    JAMA Ophthalmol; 2022 Jul; 140(7):707-714. PubMed ID: 35679030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The B-VITAGE trial: a randomized trial of homocysteine lowering treatment of depression in later life.
    Ford AH; Flicker L; McCaul K; van Bockxmeer F; Hegarty S; Hirani V; Fenner S; Almeida OP
    Trials; 2010 Jan; 11():8. PubMed ID: 20096138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Beyond Ageing Project Phase 2--a double-blind, selective prevention, randomised, placebo-controlled trial of omega-3 fatty acids and sertraline in an older age cohort at risk for depression: study protocol for a randomized controlled trial.
    Cockayne NL; Duffy SL; Bonomally R; English A; Amminger PG; Mackinnon A; Christensen HM; Naismith SL; Hickie IB
    Trials; 2015 Jun; 16():247. PubMed ID: 26037484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Vitamin D and Omega-3 Fatty Acid Supplementation on Kidney Function in Patients With Type 2 Diabetes: A Randomized Clinical Trial.
    de Boer IH; Zelnick LR; Ruzinski J; Friedenberg G; Duszlak J; Bubes VY; Hoofnagle AN; Thadhani R; Glynn RJ; Buring JE; Sesso HD; Manson JE
    JAMA; 2019 Nov; 322(19):1899-1909. PubMed ID: 31703120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Vitamin D and ω-3 Fatty Acid Supplementation on Risk of Age-Related Macular Degeneration: An Ancillary Study of the VITAL Randomized Clinical Trial.
    Christen WG; Cook NR; Manson JE; Buring JE; Chasman DI; Lee IM; Bubes V; Li C; Haubourg M; Schaumberg DA;
    JAMA Ophthalmol; 2020 Dec; 138(12):1280-1289. PubMed ID: 33119047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison between the AA/EPA ratio in depressed and non depressed elderly females: omega-3 fatty acid supplementation correlates with improved symptoms but does not change immunological parameters.
    Rizzo AM; Corsetto PA; Montorfano G; Opizzi A; Faliva M; Giacosa A; Ricevuti G; Pelucchi C; Berra B; Rondanelli M
    Nutr J; 2012 Oct; 11():82. PubMed ID: 23046564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Long-term Vitamin D3 Supplementation vs Placebo on Risk of Depression or Clinically Relevant Depressive Symptoms and on Change in Mood Scores: A Randomized Clinical Trial.
    Okereke OI; Reynolds CF; Mischoulon D; Chang G; Vyas CM; Cook NR; Weinberg A; Bubes V; Copeland T; Friedenberg G; Lee IM; Buring JE; Manson JE
    JAMA; 2020 Aug; 324(5):471-480. PubMed ID: 32749491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MTHFR 677C → T genotype modulates the effect of a 5-year supplementation with B-vitamins on homocysteine concentration: The SU.FOL.OM3 randomized controlled trial.
    Fezeu LK; Ducros V; Guéant JL; Guilland JC; Andreeva VA; Hercberg S; Galan P
    PLoS One; 2018; 13(5):e0193352. PubMed ID: 29813097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.